Clinical Trials List
Protocol NumberH9S-MC-JDCG
2012-06-01 - 2015-05-31
Phase II
Terminated3
-
Trial Applicant
ELI LILLY AND COMPANY(TAIWAN), INC.
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2025/08/20
Investigators and Locations
Co-Principal Investigator
- Chien-Yuan Chen Division of Hematology & Oncology
- Shang-Ju Wu Division of Hematology & Oncology
- - - Division of Hematology & Oncology
- HSIN-AN HOU Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Stop recruiting
Co-Principal Investigator
- Jyh-Pyng Gau Division of Hematology & Oncology
- 洪英中 Division of Hematology & Oncology
- Liang-Tsai Hsiao Division of Hematology & Oncology
- 余垣斌 Division of Hematology & Oncology
- Jin-Hwang Liu Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Stop recruiting
Co-Principal Investigator
- 何景良 Division of Hematology & Oncology
- 葉人華 Division of Hematology & Oncology
- 戴明燊 Division of Hematology & Oncology
- TSU-YI CHAO Division of Hematology & Oncology
- 張平穎 Division of Hematology & Oncology
- Tsu-Yi Chao Division of Hematology & Oncology
- 高偉堯 Division of Hematology & Oncology
- 黃子權 Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Stop recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
20 participants
-
Global
213 participants
